0001209191-19-050616.txt : 20190925
0001209191-19-050616.hdr.sgml : 20190925
20190925142053
ACCESSION NUMBER: 0001209191-19-050616
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190918
FILED AS OF DATE: 20190925
DATE AS OF CHANGE: 20190925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klopp John Michael
CENTRAL INDEX KEY: 0001789348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33004
FILM NUMBER: 191113690
MAIL ADDRESS:
STREET 1: ONE GATEWAY CENTER, SUITE 351
STREET 2: 300 WASHINGTON STREET
CITY: NEWTON
STATE: MA
ZIP: 02458
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acer Therapeutics Inc.
CENTRAL INDEX KEY: 0001069308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320426967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
BUSINESS PHONE: (844) 902-6100
MAIL ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
FORMER COMPANY:
FORMER CONFORMED NAME: Opexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20060616
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaFrontiers Corp.
DATE OF NAME CHANGE: 20051011
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMAFRONTIERS CORP
DATE OF NAME CHANGE: 20040816
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-18
0
0001069308
Acer Therapeutics Inc.
ACER
0001789348
Klopp John Michael
C/O ACER THERAPEUTICS INC.
ONE GATEWAY CENTER, SUITE 351
NEWTON
MA
02458
0
1
0
0
Chief Technology Officer
Employee Stock Option (right to buy)
3.42
2019-09-18
4
A
0
50000
0.00
A
2029-09-18
Common Stock
50000
50000
D
The option vests and becomes exercisable as follows: 50% on 01/01/2021 and 50% on 01/01/2022.
/s/ Harry Palmin, Attorney-in-fact
2019-09-25